The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues
Previously, we showed that a nitric oxide synthase (NOS) inhibitor, compound T1023, induces transient hypoxia and prevents acute radiation syndrome (ARS) in mice. Significant efficacy (according to various tests, dose modifying factor (DMF)—1.6–1.9 against H-ARS/G-ARS) and safety in radioprotective...
Main Authors: | Marina Filimonova, Alina Saburova, Victoria Makarchuk, Ljudmila Shevchenko, Valentina Surinova, Vadim Yuzhakov, Nina Yakovleva, Larisa Sevankaeva, Vyacheslav Saburov, Sergey Koryakin, Petr Shegay, Andrey Kaprin, Sergey Ivanov, Alexander Filimonov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9340 |
Similar Items
-
1-Isobutanoil-2-isopropylisothiourea Phosphate, T1082: A Safe and Effective Prevention of Radiotherapy Complications in Oncology
by: Marina Filimonova, et al.
Published: (2022-02-01) -
The influence of nitric oxide synthases inhibitor Т1023 on the development of radiation pneumofibrosis in rats
by: A. S. Saburova, et al.
Published: (2020-03-01) -
Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs
by: Marina Filimonova, et al.
Published: (2022-09-01) -
Influence of the type of salt-forming acids on the antiradiation activity of T1023 analogs – salts of N-isobutanoyl-S-isopropylisothiourea
by: M. V. Filimonova, et al.
Published: (2021-04-01) -
Combination of NOS- and PDK-Inhibitory Activity: Possible Way to Enhance Antitumor Effects
by: Marina Filimonova, et al.
Published: (2022-01-01)